• Viridian Therapeutics (NASDAQ:VRDN) Receives "Buy" Rating from Needham & Company LLC

    Source: Buzz FX / 25 Nov 2024 08:21:10   America/New_York


    Viridian Therapeutics (NASDAQ:VRDN) Receives "Buy" Rating from Needham & Company LLC Written by MarketBeat November 25, 2024 Share Link copied to clipboard. Viridian Therapeutics ( NASDAQ:VRDN - Get Free Report ) 's stock had its "buy" rati
    Read more...
Share on,